These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 961756)

  • 1. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
    Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
    Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and TSH responses to TRH, chlorpromazine and L-dopa in children with human growth hormone deficiency.
    Okada Y; Onishi T; Tanaka K; Morimoto S; Tsuji M; Watanabe K; Okazaki A; Takeuchi T; Kumahara Y
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):217-26. PubMed ID: 96645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
    Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.
    Diefenbach WP; Carmel PW; Frantz AG; Ferin M
    J Clin Endocrinol Metab; 1976 Sep; 43(3):638-42. PubMed ID: 821963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
    Muechler EK; Huang KE; McDonald JV; Tang L
    Am J Obstet Gynecol; 1987 Aug; 157(2):453-5. PubMed ID: 3113252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary control of perinatal prolactin secretion in Macaca mulatta.
    Epstein MF; Chez RA; Oakes GK; Vaitukaitis JL
    Endocrinology; 1976 Sep; 99(3):743-51. PubMed ID: 821744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpuerperal lactation and normal prolactin regulation.
    Malarkey WB
    J Clin Endocrinol Metab; 1975 Feb; 40(2):198-204. PubMed ID: 1168856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of acute changes in prolactin to affect DHEA-S secretion in the human.
    Wiebe RH; Handwerger S
    J Reprod Med; 1983 Mar; 28(3):206-8. PubMed ID: 6222183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin secretion in Huntington's disease.
    Levy CL; Carlson HE; Sowers JR; Goodlett RE; Tourtellotte WW; Hershman JM
    Life Sci; 1979 Feb; 24(8):743-9. PubMed ID: 155768
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
    Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of L-dopa on human prolactin release during sleep.
    Chihara K; Kato Y; Maeda K; Ohgo S; Imura H
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):19-27. PubMed ID: 174362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE
    J Clin Endocrinol Metab; 1986 Jul; 63(1):249-51. PubMed ID: 3086358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
    Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
    Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
    Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
    Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.